Cargando…

Reinforcing Science and Policy, With Suggestions for Future Research: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"

Oortwijn et al continue their guide to good practice in the use of deliberative processes in health technology assessment (HTA) based on a survey of international practice. This is useful, and I applaud their care in maintaining objectivity, especially regarding the treatment of moral and politicall...

Descripción completa

Detalles Bibliográficos
Autor principal:	Culyer, Anthony J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kerman University of Medical Sciences 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125096/ https://www.ncbi.nlm.nih.gov/pubmed/35942975 http://dx.doi.org/10.34172/ijhpm.2022.7398

Ejemplares similares

Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: DiStefano, Michael J.
Publicado: (2022)

Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Guzman, Javier
Publicado: (2022)

Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Bond, Kenneth
Publicado: (2022)

Evidence-Informed Deliberative Processes for UHC: Progress, Potential and Prudence: Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide"
por: Gopinathan, Unni
Publicado: (2023)

Use of Evidence-Informed Deliberative Processes – Learning by Doing: Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Culyer, Anthony J.
Publicado: (2019)

Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage: Comment on "Evidence-Informed Deliberative Processes for Health Benefits Package Design – Part II: A Practical Guide"
por: Sajadi, Haniye Sadat, et al.
Publicado: (2022)

Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide
por: Oortwijn, Wija, et al.
Publicado: (2021)

Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework
por: Baltussen, Rob, et al.
Publicado: (2021)

How to Account for Asymmetries in Deliberative Dialogues: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Jiménez-Pernett, Jaime
Publicado: (2023)

The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan
por: Oortwijn, Wija, et al.
Publicado: (2022)

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Gopinathan, Unni, et al.
Publicado: (2020)

Evidence-Informed Deliberative Processes for Universal Health Coverage: Broadening the Scope: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Gopinathan, Unni, et al.
Publicado: (2016)

The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran
por: Nouhi, Mojtaba, et al.
Publicado: (2022)

Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Goetghebeur, Mireille, et al.
Publicado: (2020)

Enhancing Multiple Ways of Knowing: Comment on "Evaluating Public Participation in a Deliberative Dialogue: A Single Case Study"
por: Boydell, Katherine M.
Publicado: (2023)

Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA: Comment on "Ethics in HTA: Examining the ‘Need for Expansion’"
por: Culyer, Anthony J.
Publicado: (2019)

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Isaranuwatchai, Wanrudee, et al.
Publicado: (2018)

Don’t Discount Societal Value in Cost-Effectiveness: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
por: Hall, William
Publicado: (2017)

Using deliberative techniques to engage the community in policy development
por: Gregory, Judy, et al.
Publicado: (2008)

Evaluating deliberative dialogues focussed on healthy public policy
por: Lavis, John N, et al.
Publicado: (2014)

Evaluating Social Protection Policies With an Implementation Science Framework: India’s Direct Benefit Transfer for Tuberculosis: Comment on "Does Direct Benefit Transfer Improve Outcomes Among People With Tuberculosis? – A Mixed-Methods Study on the Need for a Review of the Cash Transfer Policy in India"
por: Schraufnagel, Ann M., et al.
Publicado: (2023)

Priority Setting for Universal Health Coverage: We Need to Focus Both on Substance and on Process: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, not Just More Evidence on Cost-Effectiveness"
por: Lauer, Jeremy A., et al.
Publicado: (2017)

Evidence based policy making during times of uncertainty through the lens of future policy makers: four recommendations to harmonise and guide health policy making in the future
por: Françoise, Margaux, et al.
Publicado: (2022)

Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
por: Bentley, Colene, et al.
Publicado: (2019)

Comment on Haig et al. (2016): the conservation genetics juggling act: integrating genetics and ecology, science and policy
por: Smith, Christian T., et al.
Publicado: (2016)

A Comment on the Science of Hair Aging
por: Trüeb, Ralph M, et al.
Publicado: (2018)

Deliberative democracy in health care: current challenges and future prospects
por: Safaei, Jalil
Publicado: (2015)

Author's response to comments on "Epidemiologic Measures and Policy Formulation"
por: Greenland, Sander
Publicado: (2005)

Citizen Science in Deliberative Systems: Participation, Epistemic Injustice, and Civic Empowerment
por: Herzog, Lisa, et al.
Publicado: (2022)

A Social, Not a Natural Science: Engaging With Broader Fields in Health Policy Analysis: Comment on "Modelling the Health Policy Process: One Size Fits All or Horses for Courses?"
por: Parkhurst, Justin
Publicado: (2023)

Pharmaceutical policy Part 1 The challenge to pharmacists to engage in policy development
por: Morrow, Norman C
Publicado: (2015)

Benefits of future clean air policies in Europe: Proposed analyses of the mortality impacts of PM(2.5) and NO(2)
por: Hoffmann, Barbara, et al.
Publicado: (2022)

Science, Policy, and the Transparency of Values
por: Elliott, Kevin C., et al.
Publicado: (2014)

The Impact of Deliberative Strategy Dissociates ERP Components Related to Conflict Processing vs. Reinforcement Learning
por: Warren, Christopher M., et al.
Publicado: (2012)

Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015)

Evidence-Informed Policy-Making: Are We Doing Enough?: Comment on "Examining and Contextualizing Approaches to Establish Policy Support Organizations – A Mixed Method Study"
por: Ellen, Moriah E., et al.
Publicado: (2022)

The Geopolitics of Health Science Research: Comment on "The Roles of Regional Organisations in Strengthening Health Research Systems in Africa: Activities, Gaps, and Future Perspectives"
por: Carmody, Pádraig
Publicado: (2022)

The Future of Disease Control Priorities: Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy"
por: Jha, Prabhat
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fa3qojae2h8e5s561bla7dou5c